标题/作者	年份
Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) IH de Boer, K Khunti, T Sadusky, KR Tuttle, JJ Neumiller, CM Rhee, ... Diabetes Care 45 (12), 3075-3090	2022
Management of blood pressure in patients with chronic kidney disease not receiving dialysis: synopsis of the 2021 KDIGO clinical practice guideline CRV Tomson, AK Cheung, JFE Mann, TI Chang, WC Cushman, SL Furth, ... Annals of internal medicine 174 (9), 1270-1281	2021
Therapeutic trials in adult FSGS: lessons learned and the road forward AS De Vriese, JF Wetzels, RJ Glassock, S Sethi, FC Fervenza Nature reviews Nephrology 17 (9), 619-630	2021
Guideline-driven management of hypertension: an evidence-based update RM Carey, JT Wright Jr, SJ Taler, PK Whelton Circulation research 128 (7), 827-846	2021
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial DC Wheeler, N Jongs, BV Stefansson, GM Chertow, T Greene, FF Hou, ... Nephrology Dialysis Transplantation 37 (9), 1647-1656	2022
Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium JI Shin, AR Chang, ME Grams, J Coresh, SH Ballew, A Surapaneni, ... Hypertension 78 (4), 1042-1052	2021
Chronic kidney disease: Strategies to retard progression MT Yan, CT Chao, SH Lin International journal of molecular sciences 22 (18), 10084	2021
Hypertension in children and adolescents: A consensus document from ESC Council on Hypertension, European Association of Preventive Cardiology, European Association of Cardiovascular Imaging, Association of Cardiovascular Nursing & Allied Professions, ESC Council for Cardiology Practice and Association for European Paediatric and Congenital Cardiology G De Simone, C Mancusi, H Hanssen, S Genovesi, E Lurbe, G Parati, ... European heart journal 43 (35), 3290-3301	2022
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome A Trautmann, O Boyer, E Hodson, A Bagga, DS Gipson, S Samuel, ... Pediatric Nephrology 38 (3), 877-919	2023
Diagnostic performance of office versus ambulatory blood pressure in kidney transplant recipients M Korogiannou, P Sarafidis, MP Theodorakopoulou, ME Alexandrou, ... American Journal of Nephrology 52 (7), 548-558	2021
Renin–angiotensin system blockers during the COVID-19 pandemic: an update for patients with hypertension and chronic kidney disease MP Theodorakopoulou, ME Alexandrou, AK Boutou, CJ Ferro, A Ortiz, ... Clinical kidney journal 15 (3), 397-406	2022
Advances in the management of primary membranous nephropathy and rituximab-refractory membranous nephropathy M Teisseyre, M Cremoni, S Boyer-Suavet, C Ruetsch, D Graça, ... Frontiers in Immunology 13, 859419	2022
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial HJL Heerspink, J Radhakrishnan, CE Alpers, J Barratt, S Bieler, U Diva, ... The Lancet 401 (10388), 1584-1594	2023
C5a receptor inhibitor avacopan in immunoglobulin A nephropathy—An open-label pilot study A Bruchfeld, H Magin, P Nachman, S Parikh, R Lafayette, A Potarca, ... Clinical kidney journal 15 (5), 922-928	2022
Lupus nephritis: new progress in diagnosis and treatment C Yu, P Li, X Dang, X Zhang, Y Mao, X Chen Journal of Autoimmunity, 102871	2022
How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies T Humphrey, MR Davids, MY Chothia, R Pecoits-Filho, C Pollock, ... Clinical Kidney Journal 15 (4), 727-737	2022
Prevalence of neural epidermal growth factor-like 1-and exostosin 1/exostosin 2-associated membranous nephropathy: a single-center retrospective study in Japan T Iwakura, C Ema, S Isobe, T Fujikura, N Ohashi, A Kato, H Yasuda Scientific Reports 12 (1), 2967	2022
Role of renin-angiotensin system blockade in advanced CKD: to use or not to use? M Mukoyama, T Kuwabara Hypertension Research 45 (6), 1072-1075	2022
C3 glomerulopathy: understanding an ultra‐rare complement‐mediated renal disease AK Heiderscheit, JJ Hauer, RJH Smith American Journal of Medical Genetics Part C: Seminars in Medical Genetics …	2022
Chronic Kidney Disease in Boys with Posterior Urethral Valves–Pathogenesis, Prognosis and Management R Klaus, B Lange-Sperandio Biomedicines 10 (8), 1894	2022

1 - 20

计算机程序会自动估算并确定日期和引用次数。